Page last updated: 2024-11-04

suramin and Carcinoma, Papillary

suramin has been researched along with Carcinoma, Papillary in 1 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trieb, K1
Dorfinger, K1
Neuhold, N1
Selzer, E1
Wilfing, A1
Czernin, S1
Hermann, M1
Niederle, B1
Gessl, A1
Vierhapper, H1

Other Studies

1 other study available for suramin and Carcinoma, Papillary

ArticleYear
Suramin affects differentiated and undifferentiated human thyroid epithelial cells in vitro.
    The Journal of endocrinology, 1992, Volume: 134, Issue:3

    Topics: Adenylyl Cyclases; Carcinoma; Carcinoma, Papillary; Cell Adhesion Molecules; Cell Differentiation; C

1992